3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Lung Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Melanoma
2
Hematologic Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Syndrome
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Psoriasis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
HIV Infections
1
Fatigue
1
Endometrial Neoplasms
1
Dyspnea
1
Disease
1
Crohn Disease
1
Cough
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
pembrolizumab
18
Specimen Handling
17
Magnetic Resonance Spectroscopy
12
Biopsy
12
Paclitaxel
9
Carboplatin
8
Radiosurgery
7
Nivolumab
7
trastuzumab deruxtecan
6
Pemetrexed
6
Leucovorin
6
Irinotecan
6
Fulvestrant
6
Fluorouracil
6
Bevacizumab
6
palbociclib
5
Oxaliplatin
5
Letrozole
5
Gemcitabine
5
Cetuximab
5
Taxes
4
Cisplatin
4
Capecitabine
4
olaparib
3
enzalutamide
3
durvalumab
3
Ipilimumab
3
Docetaxel
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Educational Status
×
30 days
×
Clear all
NCT04960787
2026-05-14
CREDIT
SWOG Cancer Research Network
Phase NA
Active not recruiting
331 enrolled